Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Olema Pharmaceuticals, Inc. (OLMA) had Return on Investments of -31.66% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-129.47M |
|
-- |
|
-- |
|
$142.26M |
|
$-142.26M |
|
$12.78M |
|
$-129.47M |
|
$-129.47M |
|
$-129.47M |
|
$-129.47M |
|
$-129.47M |
|
$-129.47M |
|
$-142.26M |
|
$-141.87M |
|
58.74M |
|
58.74M |
|
$-2.20 |
|
$-2.20 |
|
| Balance Sheet Financials | |
$438.47M |
|
-- |
|
$12.51M |
|
$450.98M |
|
$41.76M |
|
-- |
|
$0.26M |
|
$42.02M |
|
$408.96M |
|
$408.96M |
|
$408.96M |
|
74.31M |
|
| Cash Flow Statement Financials | |
$-104.35M |
|
$-93.53M |
|
$268.82M |
|
$68.54M |
|
$139.48M |
|
$70.94M |
|
$22.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-104.51M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-31.66% |
|
-31.66% |
|
-28.71% |
|
|
Return on Investments |
-31.66% |
$5.50 |
|
$-1.78 |
|
$-1.78 |
|